Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Considerations in the development of generic disease therapies for multiple sclerosis.
Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
A Clinical Decision Support System with an Integrated EMR for Diagnosis of Peripheral Neuropathy.
Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.
Information exchange.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
The best basic science paper on multiple sclerosis in 2012: Commentary.
Neurologic Diseases in Special Care Patients.
MHC haplotype-dependent regulation of MOG-induced EAE in rats.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
MicroRNA 182 inhibits CD4(+)CD25(+)Foxp3(+) Treg differentiation in experimental autoimmune encephalomyelitis.
Two cases of chronic immune sensorimotor polyradiculopathy: Expanding the spectrum of chronic immune polyradiculopathies.
Partial oculomotor nerve palsy in a 7-year-old child.
Physical Activity and Its Correlates in Youth with Multiple Sclerosis.
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Metabolic response to glatiramer acetate therapy in multiple sclerosis patients.
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-Commentary.
Rapid measurement of brain macromolecular proton fraction with transient saturation transfer MRI.
Calpain Inhibition Reduces Structural and Functional Impairment of Retinal Ganglion Cells in Experimental Optic Neuritis.
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.
Importance of early treatment initiation in the clinical course of multiple sclerosis.
Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.
Pages
« first
‹ previous
…
741
742
743
744
745
746
747
748
749
…
next ›
last »